In vitro corrosion study of PLA/Mg composites for cardiovascular stent applications.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34607299.
- Also identified by DOI 10.1016/j.jmbbm.2021.104768.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The present investigation explores the impact of Mg volume fraction (V<sub>Mg</sub>) as a controlling parameter of degradation rate in designing patient-specific cardiovascular stents made of PLA/Mg composites. For the purpose of this research, PLA/Mg composite plates containing 1, 3, 5, and 10% V<sub>Mg</sub> are produced by melt blending and hot press molding. Characterization techniques such as scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and X-ray diffraction (XRD) are employed to study the microstructure of PLA/Mg composites. For in vitro corrosion tests, stent prototypes and composite samples are immersed in baths of simulated body fluid (SBF). According to in vitro corrosion tests, increasing V<sub>Mg</sub> increases the corrosion rate of the composites by accelerating the corrosion of the particles and the crystalline zones surrounding them. In addition, a 2% raise in the Mg content (from 1% to 3%), increases the overall Mg weight loss by more than 4 times. Composite samples and prototype stents containing more than 5% V<sub>Mg</sub> exhibit cracking and brittleness after 7 days of immersion in SBF. In light of the compression tests results and also the failures and cracks observed during immersions, the upper limit of Mg content for PLA/Mg stent fabrication purposes is found to be below 3%.
Medical subject headings
- Biocompatible Materials
- Stents